Inhibition of cancer stem cell like cells by a synthetic retinoid
The discovery of efficient drugs is a main challenge in cancer therapy. Here, the authors report a synthetic retinoid, WYC-209 with anti-tumor and anti-metastatic activity mediated by the retinoic acid receptor signaling pathway.
Main Authors: | Junwei Chen, Xin Cao, Quanlin An, Yao Zhang, Ke Li, Wenting Yao, Fuchun Shi, Yanfang Pan, Qiong Jia, Wenwen Zhou, Fang Yang, Fuxiang Wei, Ning Wang, Biao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-03877-7 |
Similar Items
-
Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway
by: Feng Qi, et al.
Published: (2021-09-01) -
Synthetic retinoids
by: Barnard, Jonathan Harold
Published: (2010) -
Growth-inhibitory Mechanisms of Synthetic Retinoids on Human Gastric Cancer Cells
by: 林鼎晏
Published: (1997) -
Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids
by: Manuela Valsecchi, et al.
Published: (2010-07-01) -
The development and use of infrared micro-spectroscopic techniques to monitor the differentiation of pluripotent stem cells induced by retinoic acid and synthetic retinoid analogues
by: Clemens, Graeme
Published: (2014)